Avacta Group Plc Company Profile (LON:AVCT)

About Avacta Group Plc

Avacta Group Plc logoAvacta Group plc is a biotechnology company. The Company is a developer of Affimer bio therapeutics and research reagents. Its segments include Animal Health, which provides tools and contract services to assist diagnosis of conditions in animals to enable treatment for veterinarians, and Life Sciences, which provides reagents and arrays for diagnostics, drug and biomarker discovery in biotech research and development. Its in-house programs include Oncology, which is engaged in developing combination therapies combining multiple immune checkpoint inhibitors by making bi- and tri-specific Affimer constructs, and Blood clotting disorders, which allows Affimer therapeutics to generate the modulate blood clot formation with the potential for anti-thrombotic, as well as wound healing therapies. It focuses on its Affimer technology, which is an engineered alternative to antibodies that has application in Life Sciences for diagnostics, therapeutics and general research and development.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: AVCT
  • CUSIP:
Key Metrics:
  • Previous Close: $0.85
  • 50 Day Moving Average: $70.92
  • 200 Day Moving Average: $85.71
  • 52-Week Range: GBX 67 - GBX 119.50
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $44.30M
  • Outstanding Shares: 65,146,000
Additional Links:

Analyst Ratings

Consensus Ratings for Avacta Group Plc (LON:AVCT) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: GBX 200

Analysts' Ratings History for Avacta Group Plc (LON:AVCT)
Show:
DateFirmActionRatingPrice TargetDetails
1/20/2017FinnCapReiterated RatingCorporateGBX 200View Rating Details
8/1/2016Numis Securities LtdReiterated RatingBuyView Rating Details
(Data available from 2/21/2015 forward)

Earnings

Earnings History for Avacta Group Plc (LON:AVCT)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Avacta Group Plc (LON:AVCT)
Current Year EPS Consensus Estimate: $-5.37 EPS

Dividends

Dividend History for Avacta Group Plc (LON:AVCT)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Avacta Group Plc (LON:AVCT)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/21/2016Mike OwenInsiderBuy7,763GBX 90£6,986.70
7/7/2016Albin,Michael ScottInsiderBuy3,393GBX 92£3,121.56
4/29/2016Slater ,CraigInsiderBuy2,222GBX 113£2,510.86
4/6/2016Albin,Michael ScottInsiderBuy899GBX 116£1,042.84
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Avacta Group Plc (LON:AVCT)
DateHeadline
proactiveinvestors.co.uk logo2016 'a really excellent year of progress' says Avacta CEO (LON:AVCT)
www.proactiveinvestors.co.uk - January 23 at 3:48 PM
proactiveinvestors.co.uk logoAvacta Group expects first licensing deal in 2017 (LON:AVCT)
www.proactiveinvestors.co.uk - January 20 at 3:30 AM
4-traders.com logoAvacta : Trading Update (LON:AVCT)
www.4-traders.com - January 20 at 3:30 AM
News IconFinncap Reiterated Avacta Group PLC (LON:AVCT) As 'Corporate' - UK Market News (LON:AVCT)
www.ukmarketnews.co.uk - January 12 at 3:50 PM
News IconDirector Dealing and Issue of Equity - Military Technologies (LON:AVCT)
military-technologies.net - January 6 at 8:51 PM
News IconAvacta Group Plc AVCT Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (LON:AVCT)
www.bioportfolio.com - January 6 at 3:50 PM
publicnow.com logoDirector Dealing and Issue of Equity (LON:AVCT)
www.publicnow.com - January 5 at 4:03 PM
News IconTechnical Buzz on Avacta Group Plc (AIM:AVCT) - The Business Journal (LON:AVCT)
belmontbusinessjournal.com - December 22 at 2:49 AM
News IconChecking the Levels on Shares of Avacta Group Plc (AIM:AVCT) - The Business Journal (LON:AVCT)
belmontbusinessjournal.com - December 20 at 9:02 PM
News IconHas Avacta Group Plc (AIM:AVCT) Got Enough Cash To Cover Its Short-Term Obligations? - Simply Wall St (LON:AVCT)
simplywall.st - December 14 at 4:26 PM
live-pr.com logoNew Market Research Report: Avacta Group Plc (AVCT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile (LON:AVCT)
www.live-pr.com - December 6 at 12:33 PM
publicnow.com logoNotice of AGM, Accounts and Directorate Change (LON:AVCT)
www.publicnow.com - December 1 at 3:46 PM
publicnow.com logoTechnical Update: Affinity Separation (LON:AVCT)
www.publicnow.com - November 23 at 12:29 PM
News IconWorld-leading cancer stem cell expert joins Avacta Scientific Advisory Board (LON:AVCT)
www.the-scientist.com - November 8 at 9:17 PM
ft.com logo[$$] Small-cap focus: biotech (LON:AVCT)
www.ft.com - November 4 at 2:05 PM
publicnow.com logoCAR-T Cell Therapy Research Collaboration in US (LON:AVCT)
www.publicnow.com - November 2 at 12:48 PM
proactiveinvestors.co.uk logoCity broker expecting big things from Avacta (LON:AVCT)
www.proactiveinvestors.co.uk - November 1 at 3:41 PM
publicnow.com logoResults from first Affimer pre-clinical studies (LON:AVCT)
www.publicnow.com - November 1 at 3:41 PM
4-traders.com logoAvacta : Director's Dealing (LON:AVCT)
www.4-traders.com - October 21 at 8:40 PM
publicnow.com logoPrelim Results for the Year Ended 31 July 2016 (LON:AVCT)
www.publicnow.com - October 17 at 8:30 AM
biz.yahoo.com logoFull Year 2016 Avacta Group PLC Earnings Release - Before Market Open (LON:AVCT)
biz.yahoo.com - October 17 at 8:30 AM
4-traders.com logoAvacta : Notice of Results (LON:AVCT)
www.4-traders.com - September 26 at 3:48 PM
News IconPositive results from first preclinical in-vivo studies of Affimer therapeutics (LON:AVCT)
www.pharmiweb.com - September 24 at 8:58 AM
4-traders.com logoAvacta : Positive results from first preclinical studies (LON:AVCT)
www.4-traders.com - September 22 at 9:34 AM
publicnow.com logoPositive results from first preclinical studies (LON:AVCT)
www.publicnow.com - September 22 at 9:34 AM
News Icon"Detroit Medical Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Published (LON:AVCT)
reports.pr-inside.com - September 13 at 8:29 AM
4-traders.com logoAvacta : Change of Adviser (LON:AVCT)
www.4-traders.com - September 12 at 3:37 PM
4-traders.com logoAvacta : Change of Registered Office (LON:AVCT)
www.4-traders.com - August 31 at 3:38 PM
proactiveinvestors.co.uk logoAvacta and the antibody alternative with "endless" applications (LON:AVCT)
www.proactiveinvestors.co.uk - August 19 at 12:02 PM
publicnow.com logoNew Facilities in Cambridge and Wetherby (LON:AVCT)
www.publicnow.com - August 16 at 12:17 PM
News IconAvacta and Leeds University awarded £3.8m Medical Research Council funding to develop new diagnostic tests (LON:AVCT)
www.bioportfolio.com - August 10 at 10:05 PM
4-traders.com logoAvacta : Grant Funding (LON:AVCT)
www.4-traders.com - August 10 at 10:05 PM
publicnow.com logoGrant Funding (LON:AVCT)
www.publicnow.com - August 10 at 8:44 AM
News IconWPP Group PLC retained as Add By Numis (LON:AVCT)
myhealthbowl.com - August 7 at 8:18 AM
publicnow.com logoKey Affimer patents to be granted in Europe and US (LON:AVCT)
www.publicnow.com - August 3 at 12:18 PM
uk.finance.yahoo.com logo3 stocks set to soar after today’s news flow? (LON:AVCT)
uk.finance.yahoo.com - August 1 at 7:32 AM
4-traders.com logoAvacta : Collaboration with Glythera (LON:AVCT)
www.4-traders.com - July 14 at 3:43 PM
publicnow.com logoCollaboration with Glythera (LON:AVCT)
www.publicnow.com - July 14 at 3:28 AM
News IconAvacta Group PLC (LON:AVCT)
markets.investorschronicle.co.uk - July 8 at 11:43 AM
News IconAvacta Rapidly Generates Affimer Binders for Zika Virus Diagnostics (LON:AVCT)
www.the-scientist.com - June 30 at 3:49 PM
publicnow.com logoAffimer Binders for Zika Virus Diagnostics (LON:AVCT)
www.publicnow.com - June 22 at 3:59 AM
4-traders.com logoAvacta : Collaboration with Mologic (LON:AVCT)
www.4-traders.com - June 13 at 11:44 AM
publicnow.com logoCollaboration with Mologic (LON:AVCT)
www.publicnow.com - June 13 at 3:29 AM
uk.finance.yahoo.com logoDirectors dealings: John Laing Group chief picks up batch of shares (LON:AVCT)
uk.finance.yahoo.com - April 29 at 12:50 PM
biz.yahoo.com logoHalf Year 2016 Avacta Group PLC Earnings Release - Before Market Open (LON:AVCT)
biz.yahoo.com - April 25 at 7:07 AM
publicnow.com logoAffimer Therapeutic Platform Development Milestone (LON:AVCT)
www.publicnow.com - April 19 at 3:35 AM
publicnow.com logoInvestor Evening (LON:AVCT)
www.publicnow.com - April 5 at 3:54 AM
uk.finance.yahoo.com logoAvacta appoints scientific advisory board (LON:AVCT)
uk.finance.yahoo.com - March 8 at 10:06 AM
publicnow.com logoShare Consolidation (LON:AVCT)
www.publicnow.com - January 26 at 3:27 AM
noodls.com logoPhilippe Cotrel Appointed Chief Commercial Officer (LON:AVCT)
www.noodls.com - January 25 at 3:27 AM

Social

What is Avacta Group Plc's stock symbol?

Avacta Group Plc trades on the London Stock Exchange (LON) under the ticker symbol "AVCT."

Where is Avacta Group Plc's stock going? Where will Avacta Group Plc's stock price be in 2017?

1 analysts have issued 1 year price targets for Avacta Group Plc's stock. Their forecasts range from GBX 200 to GBX 200. On average, they anticipate Avacta Group Plc's share price to reach GBX 200 in the next twelve months.

How do I buy Avacta Group Plc stock?

Shares of Avacta Group Plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

How much does a share of Avacta Group Plc stock cost?

One share of Avacta Group Plc stock can currently be purchased for approximately GBX 68.


Last Updated on 2/21/2017 by MarketBeat.com Staff